Cancer Communications, formerly the Chinese Journal of Cancer, was founded in 1982. It has been published entirely in English since 2006, SCI indexed since Sep 2014. It has a current IF of 5.627. Cancer Communications is an open-access, peer-reviewed online journal that encompasses basic, clinical, translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular, cellular biology, genetics. 

Cancer Communications’ Editor-in-Chief
Prof. Xu Ruihua 
President of Sun Yat-sen University Cancer Center 
Vice-President of China Anti-cancer Association (CACA)
President-Elect of Chinese Society of Clinical Oncology (CSCO)
Vice President of China Medicinal Biotechnology Association (CMBA)
Chairman of Committee of targeted therapy in Oncology, Chinese Anti-Cancer Association

For more information about Cancer Communications follow the link for more: https://onlinelibrary.wiley.com/journal/25233548